Background: Both nausea and vomiting and depression are common conditions a ecting women during pregnancy. Several studies have linked depression with nausea and vomiting of pregnancy (NVP); however, researchers were unable to determine whether depression was caused by NVP or by a pre-existing condition.
Nausea and vomiting of pregnancy (NVP) is the most common medical condition of pregnancy, a ecting an estimated 50-90% of all women [1, 2] . Depression is also common during gestation, a ecting approximately 10-15% of women [3] . ere have been several studies examining the relationship between NVP and depression [4] [5] [6] [7] [8] ; however, the authors were not able to establish if depression preceded or resulted from the symptoms of NVP. In a preliminary study by our group, depression and treatment with antidepressants prior to and during early pregnancy were not associated with the occurrence of NVP; however, the severity of neither NVP nor depression were examined at that time [9] . It has also been established that prenatal depression is a predicator for postpartum depression, which occurs in approximately 13% of women [10] [11] [12] [13] ; however, it has not been examined whether depression associated with NVP is a predicator for postpartum depression.
us, it remains uncertain whether there is a cause or e ect between NVP and depression. All of the above studies had limitations and used di erent instruments to measure NVP as well as di erent tools to measure depressive symptoms. In addition, none of the women was enrolled prospectively, to rule out if there was underlying depression prior to pregnancy.
e objective of this current study was therefore to determine whether depression is associated with symptoms of NVP, using tools speci cally designed and validated for use in pregnancy.
Methods
e Motherisk Program is a counseling service located at the Hospital for Sick Children in Toronto, where information on the safety and risks of exposures to prescription and over-thecounter (OTC) medications, natural health products, chemicals, radiation, and infectious diseases during pregnancy and breastfeeding is provided for women and healthcare professionals. An observational study was conducted involving women with no prior diagnosis of depression who contacted e Motherisk program. For each woman, an intake form was completed, which documented obstetric and medical histories, including medications taken and other exposures. For this study, the Motherisk counselor receiving the call identi ed women who did not have a history of depression or any other psychiatric conditions, was planning a pregnancy or was <6 weeks pregnant, which would be prior to the advent of NVP. Participants who had been exposed to a teratogen, or had serious medical conditions such as lupus, rheumatoid arthritis, epilepsy or MS and had su cient English language skills, were excluded from the study. Woman who agreed to participate in the study were connected with the study coordinator, who explained the details of the study and obtained verbal consent to participate.
Participants who were not yet pregnant were asked to telephone the coordinator when they were 8 weeks pregnant. In addition, they were given the option to be contacted at intervals of their choice (e.g., every 3 months), via email or telephone, to remind them to contact the coordinator once a pregnancy was con rmed. Each study participant was interviewed six times; at enrollment and subsequently at 8, 11, 18, and 30 weeks gestation, with the nal interview at approximately 6-18 weeks post partum.
Together with documenting obstetrical and any other pertinent details, the Edinburgh Postnatal Depression Scale (EPDS) was administered during each interview. is tool was designed and validated to evaluate post-partum depressive symptoms and later validated for use in pregnant women [14] . Women who scored ≥13 prior to pregnancy were excluded from the study, and those who scored ≥13 at any time were asked for permission for us to contact their physicians, to make them aware of their patients' depressive symptoms, so they could institute treatment if necessary.
Details of NVP were also collected using the Pregnancy Unique uanti cation of Emesis Scoring System (PUQE), which has been validated for measuring the severity of NVP [15] . Women were also asked to rate their overall wellbeing on a scale from 0 (the worst possible) to 10 (the best possible).
EPDS, PUQE and wellbeing scales were summarized at each time point using descriptive statistics, including mean, standard deviation, median, minimum and maximum scores. Scores were then dichotomized as above or below the cuto point for moderate symptomatology and Fisher's Exact test was used to determine if any relationships existed between scores from the di erent scales.
is study received ethics approval from the Research board at the Hospital for Sick Children in Toronto, Canada.
Results
Consent to participate in the study was obtained from 80 women. Two women were excluded because they scored >12 on the EPDS prior to pregnancy and were referred to their physician. One woman was planning pregnancy when she was recruited; however, she did not contact us su ciently early in her pregnancy and was excluded. ree women did not complete all the required interviews, and withdrew from the study following the rst (n=2) and third interview (n=1). Two women had not become pregnant by the time of analysis and 15 women miscarried. e remaining 57, who completed all six follow-ups, were included in the study (see Table) . When scores were classi ed as above or below the cuto indicative of moderate-severe symptomatology (i.e., ≥7 on the PUQE and ≥13 on the EPDS), there was no correlation between scores at 8 weeks (Fisher's Exact P=0.175 for both).
As expected, PUQE scores were highest at weeks 8 and 11, although Wellbeing scores were constant over time. High scores on the EPDS and PUQE scales were examined and there were only ve EPDS scores ≥13, which would be considered indicative of depression (one at baseline and two each at weeks 8 and 11) and eleven high PUQE scores ≥7, indicative of moderate-severe NVP. No association was seen between high PUQE scores and EPDS scores or, conversely, a relationship between high EPDS scores and high PUQE scores.
Discussion
To our knowledge, this is the rst study to be conducted prospectively, beginning prior to pregnancy until and including the post partum period, attempting to nd an association with NVP and depression, using questionnaires speci cally designed and validated to measure both NVP and depression in pregnancy. Several published studies have linked NVP with depression. Kitamura and colleagues [4] administered a set of questionnaires in order to examine the severity of NVP and Zung's Self Rating Depression Score to 1329 women who were attending a prenatal clinic. ey observed that women in the depressed group had a signi cantly higher mean score of NVP than the comparison group [4] . Chou and coworkers 5 examined the relationship between psychosocial factors and incidence of NVP in 113 women. ey used the 20-item Center for Epidemiologic Studies Depression Scale (CES-D) to measure depressive symptoms and a checklist to examine the frequency of occurrence of NVP (occasional, frequent or absent) to establish NVP. ey concluded that pregnant women without NVP had signi cantly lower CES-D scores than did women with frequent NVP, suggesting that depressive symptoms were positively correlated with NVP [5] .
To measure psychiatric morbidity, Swallow and colleagues [6] evaluated 273 women using the General Health uestionnaire (GHQ), and to measure mood and illness perception, using visual analogue scales. ese scores were compared with the scores of incidence and severity of NVP, which had been measured using the NVP instrument. ey determined that high GHQ scores were associated with severe NVP [6] . Andersson and associates used the Primary Care Evaluation of Mental Disorders system for screening of depressive and anxiety disorders in 1495 women diagnosed with antenatal depression and anxiety. ey concluded that women with a psychiatric diagnosis su ered from more NVP than did women with no psychiatric diagnosis [7] . Finally, Koken and ese results were compared to the total Rhodes scale score, and they found that there was an association with anxiety and depression during early pregnancy and severity of NVP [8] .
us, there appears to be a correlation between NVP and depression. e main limitation of the above studies is they did not examine this relationship prospectively; therefore, were not able to establish if depression preceded or resulted from symptoms of NVP.
In this study, an association between high PUQE scores and high EPDS scores was not evident, although high PUQE scores were associated with low Wellbeing scores. While several of the questions on the EPDS scales measure somatic symptoms, which were similar to some of the Wellbeing questions, an association was not observed between these two scores. In addition, the woman who scored highest on the EPDS scale (18) scored 4 on the PUQE scale, and the woman who scored the highest on the PUQE scale 12 scored 2 on the EPDS scale.
ere was one woman who scored 13 on 2 occasions, at 8 and 11 weeks, and at both time points, her PUQE scores were 7. Subsequently, she was treated for depression in the postpartum period. ese ndings suggest that she may have been su ering from an unidenti ed depression, which was not related to her symptoms of NVP.
e main limitation of our present study was that few of the women had severe nausea, with most cases reported as mild. A far larger sample size would be required to able to follow enough women to include individuals su ering from more severe NVP, and therefore to allow a satisfactory comparison between high EPDS scores and high PUQE scores. Nevertheless, we have demonstrated a rigorous method for conducting such a study and other researchers could use this approach to conduct a similar study.
Conclusion
We were not able to separate the cause or e ect of NVP and depression during pregnancy in this pilot study. However, with this study design, using these instruments of measurement and with a larger sample of women, it may be possible for further exploration of this important clinical question.
